CADENCE CAPITAL MANAGEMENT LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 195 filers reported holding ANI PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,087,000
-17.1%
33,605
+4.5%
0.16%
-28.8%
Q1 2020$1,311,000
-38.1%
32,168
-6.3%
0.22%
-2.6%
Q4 2019$2,118,000
-27.3%
34,348
-14.1%
0.23%
-44.9%
Q3 2019$2,915,000
-12.0%
40,003
-0.7%
0.41%
+25.1%
Q2 2019$3,311,000
-22.6%
40,284
-33.6%
0.33%
-14.0%
Q1 2019$4,277,000
+58.2%
60,630
+1.0%
0.38%
+41.0%
Q4 2018$2,703,000
-13.7%
60,047
+8.4%
0.27%
+61.5%
Q3 2018$3,131,000
+1.7%
55,384
+20.1%
0.17%
-7.1%
Q2 2018$3,080,000
+110.2%
46,108
+83.3%
0.18%
+91.6%
Q1 2018$1,465,000
-6.6%
25,161
+3.4%
0.10%
-5.0%
Q4 2017$1,568,000
-10.6%
24,326
-27.2%
0.10%
-9.1%
Q3 2017$1,753,000
+486.3%
33,402
+422.2%
0.11%
+423.8%
Q2 2017$299,000
-0.3%
6,397
+5.7%
0.02%0.0%
Q1 2017$300,000
-41.7%
6,052
-28.7%
0.02%
-41.7%
Q4 2016$515,000
-53.9%
8,492
-49.5%
0.04%
-56.1%
Q3 2016$1,117,000
+18.1%
16,829
-0.7%
0.08%
+15.5%
Q2 2016$946,000
+71.4%
16,941
+3.4%
0.07%
+82.1%
Q1 2016$552,000
+66.8%
16,387
+123.7%
0.04%
+77.3%
Q4 2015$331,000
+7.1%
7,327
-6.4%
0.02%0.0%
Q3 2015$309,000
-51.0%
7,824
-23.0%
0.02%
-37.1%
Q2 2015$631,000
-39.3%
10,164
-38.8%
0.04%
-45.3%
Q1 2015$1,040,00016,6200.06%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders